| 30th May 2019 11:00 am |
RNS |
Price Monitoring Extension |
| 30th May 2019 7:01 am |
RNS |
Positive Results for NXP001 Clinical Trial |
| 28th May 2019 7:00 am |
RNS |
Holding(s) in Company - Amendment |
| 24th May 2019 7:30 am |
RNS |
Holding(s) in Company |
| 24th May 2019 7:00 am |
RNS |
Loan Conversion |
| 22nd May 2019 7:00 am |
RNS |
Holding(s) in Company |
| 22nd May 2019 7:00 am |
RNS |
Holding(s) in Company |
| 22nd May 2019 7:00 am |
RNS |
Holding(s) in Company |
| 15th May 2019 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 15th May 2019 4:35 pm |
RNS |
Price Monitoring Extension |
| 15th May 2019 7:00 am |
RNS |
Nuformix Achieves 2nd NXP001 Development Milestone |
| 10th May 2019 9:00 am |
RNS |
Price Monitoring Extension |
| 8th May 2019 7:30 am |
RNS |
Holding(s) in Company |
| 9th Apr 2019 7:00 am |
RNS |
Strategic Cannabinoid Agreement |
| 5th Apr 2019 7:00 am |
RNS |
Notification Major Share Interests |
| 22nd Mar 2019 7:00 am |
RNS |
Nuformix Commences NXP001 Clinical Trial |
| 27th Feb 2019 7:00 am |
RNS |
MHRA approval for NXP001 |
| 20th Feb 2019 6:16 pm |
RNS |
Holding(s) in Company |
| 20th Dec 2018 7:00 am |
RNS |
Unaudited Half Year Results |
| 3rd Dec 2018 7:00 am |
RNS |
Reports Results from Novel IPF Pre-Clinical Trial |
| 27th Nov 2018 7:00 am |
RNS |
Expansion of NXP001 Agreement & Milestone Payment |
| 28th Sep 2018 10:09 am |
RNS |
Director/PDMR Shareholding |
| 28th Sep 2018 7:00 am |
RNS |
Additional New NXP002 Patent Filing |
| 19th Sep 2018 2:33 pm |
RNS |
Result of AGM |
| 14th Sep 2018 7:00 am |
RNS |
NXP001 Pre-Clinical Milestone Achieved |
| 28th Aug 2018 12:55 pm |
RNS |
Convertible Loan Amendment |
| 16th Aug 2018 7:00 am |
RNS |
Annual Report and Notice of AGM |
| 26th Jul 2018 2:00 pm |
RNS |
Final Results |
| 9th Jul 2018 9:33 am |
RNS |
Holding(s) in Company |
| 2nd Jul 2018 7:00 am |
RNS |
Operational Update |
| 26th Jun 2018 8:00 am |
RNS |
Collaboration with SGSC |
| 11th May 2018 7:00 am |
RNS |
Dr Chris Blackwell Appointed NED |
| 24th Apr 2018 11:54 am |
RNS |
Holding(s) in Company |
| 11th Apr 2018 4:41 pm |
RNS |
Stmnt re Share Price Movement |
| 2nd Mar 2018 1:30 pm |
RNS |
Update re: Broker |
| 27th Feb 2018 9:37 am |
RNS |
Holding(s) in Company |
| 31st Jan 2018 7:00 am |
RNS |
NXP002 Pilot Study in Lung and Liver Fibrosis |
| 15th Dec 2017 7:30 am |
RNS |
Agreement to License NXP001 |
| 14th Dec 2017 7:00 am |
RNS |
Dr Andy Richards Chairs Advisory Panel - New Appts |
| 12th Dec 2017 4:40 pm |
RNS |
Second Price Monitoring Extn |
